- Home
- SBH vs PRTA Comparison
SBH vs PRTA Comparison
Compare SBH & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- PRTA
- Stock Information
- Founded
- SBH 1964
- PRTA 2012
- Country
- SBH United States
- PRTA Ireland
- Employees
- SBH N/A
- PRTA N/A
- Industry
- SBH Other Specialty Stores
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- PRTA Health Care
- Exchange
- SBH Nasdaq
- PRTA Nasdaq
- Market Cap
- SBH 937.3M
- PRTA 809.8M
- IPO Year
- SBH 2006
- PRTA N/A
- Fundamental
- Price
- SBH $10.28
- PRTA $6.40
- Analyst Decision
- SBH Buy
- PRTA Buy
- Analyst Count
- SBH 6
- PRTA 9
- Target Price
- SBH $12.70
- PRTA $27.67
- AVG Volume (30 Days)
- SBH 1.7M
- PRTA 1.8M
- Earning Date
- SBH 08-07-2025
- PRTA 08-07-2025
- Dividend Yield
- SBH N/A
- PRTA N/A
- EPS Growth
- SBH 18.05
- PRTA N/A
- EPS
- SBH 1.76
- PRTA N/A
- Revenue
- SBH $3,698,409,000.00
- PRTA $137,935,000.00
- Revenue This Year
- SBH N/A
- PRTA N/A
- Revenue Next Year
- SBH $1.40
- PRTA $119.20
- P/E Ratio
- SBH $5.84
- PRTA N/A
- Revenue Growth
- SBH 0.17
- PRTA 54.55
- 52 Week Low
- SBH $7.54
- PRTA $4.32
- 52 Week High
- SBH $14.79
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- SBH 71.12
- PRTA 54.04
- Support Level
- SBH $8.66
- PRTA $5.96
- Resistance Level
- SBH $9.08
- PRTA $6.59
- Average True Range (ATR)
- SBH 0.32
- PRTA 0.40
- MACD
- SBH 0.16
- PRTA 0.18
- Stochastic Oscillator
- SBH 98.92
- PRTA 79.56
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).